Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2007 (16).
- As per un-audited half yearly accounts as on 30.09.07, the Company has reported net profit of Tk. 855.29 m with EPS of T
As per un-audited half yearly accounts as on 30.09.07, the Company has reported net profit of Tk. 855.29 m with EPS of Tk. 95.64 as against last year's half yearly of Tk. 747.22 m and Tk. 83.56 respectively.
- In response to a DSE query, the company has informed that there is no undisclosed price sensitive information according
In response to a DSE query, the company has informed that there is no undisclosed price sensitive information according to the prevailing rules and regulations as price sensitive information.
- The company has informed that it has credited the stock dividend for the year 2006-2007 to the respective shareholder's
The company has informed that it has credited the stock dividend for the year 2006-2007 to the respective shareholder's BO Accounts.
- In response to a DSE query, the company has informed that it has not any plan to convert the cash dividend into stock di
In response to a DSE query, the company has informed that it has not any plan to convert the cash dividend into stock dividend.
- There will be no price limit on the trading of the shares of the company today (19.08.07).
There will be no price limit on the trading of the shares of the company today (19.08.07).
- Normal trading of the shares of the company will resume on 16.08.07 after Record date.
Normal trading of the shares of the company will resume on 16.08.07 after Record date.
- Trading of the shares of the company will remain suspended on record date i.e., 15.08.07.
Trading of the shares of the company will remain suspended on record date i.e., 15.08.07.
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per spot settlement cycle with cum benefit from 12.08.07 to 14.08.07. Trading of the shares will remain suspended on record date i.e., 15.08.07.
- Mrs. Ratna Patra, one of the Sponsors of the company, has reported her intention to transfer 14,878 shares out of her to
Mrs. Ratna Patra, one of the Sponsors of the company, has reported her intention to transfer 14,878 shares out of her total holdings of 2,69,646 shares of the company to Mr. Anjan Chowdhury another Sponsor of the company by way of gift outside the trading system of the Exchange.
- As per audited accounts as on 31.03.07, the Company has reported net profit of Tk. 1303.24 m with EPS of Tk. 218.61 as a
As per audited accounts as on 31.03.07, the Company has reported net profit of Tk. 1303.24 m with EPS of Tk. 218.61 as against Tk 1165.86 m and Tk. 195.56 (restated) respectively as on 31.03.06.
- The company has informed that it has decided to increase authorized capital from existing Tk. 100 crore to Tk. 500 crore
The company has informed that it has decided to increase authorized capital from existing Tk. 100 crore to Tk. 500 crore subject to the approval of shareholders (Information received at 11:20 AM).
- There will be no price limit on the trading of the shares of the company on 17.07.07 following its corporate declaration
There will be no price limit on the trading of the shares of the company on 17.07.07 following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 50% and stock dividend @ 50% for the year ended March 31, 2007. D
The Board of Directors has recommended cash dividend @ 50% and stock dividend @ 50% for the year ended March 31, 2007. Date of AGM : 12.09.07, Time: 11.00 AM, Venue: Bangladesh-China Friendship Conference Centre, Sher-E-Bangla Nagar, Dhaka. Record Date: 15.08.07. (Information received at 11:17 AM )
- The company has informed that in accordance with the clause 30 of the Listing Regulations of DSE, a meeting of the Board
The company has informed that in accordance with the clause 30 of the Listing Regulations of DSE, a meeting of the Board of Directors of the Company scheduled to be held on 16.07.07 at 10:30 AM in regard to consider its accounts for the year ended 31.03.07, appropriation of profits and about 41st AGM of the shareholders.
- In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com
In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- The company has informed that Square Pharmaceuticals Ltd. has obtained "Certificate of CMP compliance of a Manufacturer"
The company has informed that Square Pharmaceuticals Ltd. has obtained "Certificate of CMP compliance of a Manufacturer" from the Medicines and Healthcare products Regulatory Agency (MHRA) of London on 19.05.07. This approval will help to start exporting its Finished Pharmaceutical Products to the United Kingdom as well as to enter into the Pharmaceutical markets in other European countries, in Australia, in South Africa and the GCC countries in near future.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.